Valeant’s new CFO Paul Herendeen is a ‘solid’ performer and a welcome addition to the beleaguered company, says TheStreet’s Jim Cramer. The company announced Monday that Herendeen, an executive at animal healthcare company Zoetis , will replace Robert Rosiello effective immediately. The move is the latest of several management changes at the besieged pharmaceutical company. Rosiello will remain at Valeant as executive vice president of corporate development and strategy. Herendeen has been the CFO of Zoetis since 2014.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
